158 related articles for article (PubMed ID: 27352172)
1. Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.
Chen YL; Lee CT; Lu CC; Yang SC; Chen WL; Lee YC; Yang CH; Peng SL; Su WC; Chow NH; Ho CL
PLoS One; 2016; 11(6):e0158125. PubMed ID: 27352172
[TBL] [Abstract][Full Text] [Related]
2. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW
Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527
[TBL] [Abstract][Full Text] [Related]
3. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.
Han HS; Lim SN; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Son SM; Choi SY; Lee HC; Lee OJ
J Thorac Oncol; 2012 Feb; 7(2):355-64. PubMed ID: 22157369
[TBL] [Abstract][Full Text] [Related]
4. EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
Wu SG; Kuo YW; Chang YL; Shih JY; Chen YH; Tsai MF; Yu CJ; Yang CH; Yang PC
J Thorac Oncol; 2012 Jan; 7(1):98-104. PubMed ID: 22124476
[TBL] [Abstract][Full Text] [Related]
5. Improved detection of EGFR mutations in the tumor cells enriched from the malignant pleural effusion of non-small cell lung cancer patient.
Wang Y; Liu Z; Yin H; Hu J; Zhong S; Chen W; Zhao J
Gene; 2018 Feb; 644():87-92. PubMed ID: 29097164
[TBL] [Abstract][Full Text] [Related]
6. Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples.
Guan Y; Wang ZJ; Wang LQ; Hua DF; Liu J
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173189
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer.
Soh J; Toyooka S; Aoe K; Asano H; Ichihara S; Katayama H; Hiraki A; Kiura K; Aoe M; Sano Y; Sugi K; Shimizu N; Date H
Int J Cancer; 2006 Nov; 119(10):2353-8. PubMed ID: 16921488
[TBL] [Abstract][Full Text] [Related]
9. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples.
Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y
Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433
[TBL] [Abstract][Full Text] [Related]
10. Sea-urchin-like Au nanocluster with surface-enhanced raman scattering in detecting epidermal growth factor receptor (EGFR) mutation status of malignant pleural effusion.
Wang L; Guo T; Lu Q; Yan X; Zhong D; Zhang Z; Ni Y; Han Y; Cui D; Li X; Huang L
ACS Appl Mater Interfaces; 2015 Jan; 7(1):359-69. PubMed ID: 25495142
[TBL] [Abstract][Full Text] [Related]
11. Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer.
Zhou J; Yao H; Zhao J; Zhang S; You Q; Sun K; Zou Y; Zhou C; Zhou J
Histopathology; 2015 Jun; 66(7):949-54. PubMed ID: 25257756
[TBL] [Abstract][Full Text] [Related]
12. Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients.
Shin S; Kim J; Kim Y; Cho SM; Lee KA
Clin Chem Lab Med; 2017 Oct; 55(12):1962-1969. PubMed ID: 28306520
[TBL] [Abstract][Full Text] [Related]
13. Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation.
Zou J; Bella AE; Chen Z; Han X; Su C; Lei Y; Luo H
J Int Med Res; 2014 Oct; 42(5):1110-7. PubMed ID: 25239875
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion.
Kang JY; Park CK; Yeo CD; Lee HY; Rhee CK; Kim SJ; Kim SC; Kim YK; Park MS; Yim HW
Respirology; 2015 Jan; 20(1):138-46. PubMed ID: 25302858
[TBL] [Abstract][Full Text] [Related]
15. Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma.
Son SM; Woo CG; Han HS; Lee KH; Lim YH; Lee OJ
Clin Chem Lab Med; 2020 Aug; 58(9):1547-1555. PubMed ID: 32229655
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients.
Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K
Cancer Sci; 2006 Jul; 97(7):642-8. PubMed ID: 16827805
[TBL] [Abstract][Full Text] [Related]
17. Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
Liu L; Zhan P; Zhou X; Song Y; Zhou X; Yu L; Wang J
PLoS One; 2015; 10(3):e0117032. PubMed ID: 25785456
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib.
Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K
Br J Cancer; 2006 Nov; 95(10):1390-5. PubMed ID: 17060940
[TBL] [Abstract][Full Text] [Related]
19. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.
Zhang X; Zhao Y; Wang M; Yap WS; Chang AY
Lung Cancer; 2008 May; 60(2):175-82. PubMed ID: 18061305
[TBL] [Abstract][Full Text] [Related]
20. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
